首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.
【2h】

Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.

机译:位于人β2-肾上腺素受体羧基末端的酪氨酸残基参与激动剂诱导的受体下调。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic exposure of various cell types to adrenergic agonists leads to a decrease in cell surface beta 2-adrenergic receptor (beta 2AR) number. Sequestration of the receptor away from the cell surface as well as a down-regulation of the total number of cellular receptors are believed to contribute to this agonist-mediated regulation of receptor number. However, the molecular mechanisms underlying these phenomena are not well characterized. Recently, tyrosine residues located in the cytoplasmic tails of several membrane receptors, such as the low density lipoprotein and mannose-6-phosphate receptors, have been suggested as playing an important role in the agonist-induced internalization of these receptors. Accordingly, we assessed the potential role of two tyrosine residues in the carboxyl tail of the human beta 2AR in agonist-induced sequestration and down-regulation of the receptor. Tyr-350 and Tyr-354 of the human beta 2AR were replaced with alanine residues by site-directed mutagenesis and both wild-type and mutant beta 2AR were stably expressed in transformed Chinese hamster fibroblasts. The mutation dramatically decreased the ability of the beta 2AR to undergo isoproterenol-induced down-regulation. However, the substitution of Tyr-350 and Tyr-354 did not affect agonist-induced sequestration of the receptor. These results suggest that tyrosine residues in the cytoplasmic tail of human beta 2AR are crucial determinants involved in its down-regulation.
机译:各种类型的细胞长期暴露于肾上腺素能激动剂会导致细胞表面β2-肾上腺素能受体(beta 2AR)数量减少。认为将受体隔离于细胞表面以及细胞受体总数的下调有助于这种激动剂介导的受体数目调节。但是,这些现象的分子机制尚不十分清楚。最近,已提出位于几种膜受体的胞质尾部的酪氨酸残基,例如低密度脂蛋白和甘露糖-6-磷酸受体,在激动剂诱导的这些受体的内在化中起重要作用。因此,我们评估了人类β2AR的羧基尾巴中两个酪氨酸残基在激动剂诱导的螯合和受体下调中的潜在作用。通过定点诱变将人类β2AR的Tyr-350和Tyr-354替换为丙氨酸残基,野生型和突变型β2AR在转化的中国仓鼠成纤维细胞中均稳定表达。该突变显着降低了β2AR受到异丙肾上腺素诱导的下调的能力。但是,Tyr-350和Tyr-354的取代不会影响激动剂诱导的受体螯合。这些结果表明,人β2AR细胞质尾中的酪氨酸残基是参与其下调的关键决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号